ICICI Prudential Healthcare Fund Growth
ICICI Prudential Mutual Fund
₹41.18 (+0.39%)
NAV as of 9 Oct 2026
Minimum Investment: ₹5,000
Return
3.23% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 1.88%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹5,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,103
Invested ₹1,000
▲+10.25%1 year
₹1,032
Invested ₹1,000
▲+3.23%3 years
₹1,199
Invested ₹1,000
▲+19.87%5 years
₹1,142
Invested ₹1,000
▲+14.19%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR INR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +3.23% | +19.87% | +14.19% | — |
| Cumulative returns (%) | +3.23% | +72.23% | +94.15% | — |
Fund Manager
| Manager | Sharmila D'Silva |
|---|---|
| Role | Manager |
| Manager Tenure | 4.17 yrs |
About Fund
| Date of Incorporation | 12 Jul 2018 |
|---|---|
| Fund House | ICICI Prudential Mutual Fund |
| Custodian | HDFC Bank Ltd |
| Registrar / Transfer Agent | ICICI Prudential Asset Management Co Ltd |
| Address | HDFC Bank House,Kamala Mills Compound,Senapati Bapat Marg,,Lower Parel (W), |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 12.31% |
| Dr Reddy's Laboratories Ltd | 8.26% |
| Cipla Ltd | 5.76% |
| Mankind Pharma Ltd | 5.21% |
| Alkem Laboratories Ltd | 4.87% |
| Divi's Laboratories Ltd | 4.83% |
| Biocon Ltd | 4.68% |
| Medplus Health Services Ltd | 4.15% |
| Cohance Lifesciences Ltd | 4.08% |
| Lupin Ltd | 3.80% |
| Aurobindo Pharma Ltd | 3.30% |
| Syngene International Ltd | 3.29% |
| Max Healthcare Institute Ltd Ordinary Shares | 3.10% |
| Gland Pharma Ltd | 2.97% |
| Zydus Lifesciences Ltd | 2.67% |
Investment Strategy
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Long term wealth creation
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.